HR 8269 · 119th Congress · Commerce
CLEAR LABELS Act
Bill Progress
✓
Introduced2
Committee3
House Vote4
Senate5
EnactedLatest: Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.(2026-04-14)
Plain Language Summary
[AI summary unavailable — showing source text]
[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 8269 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 8269 To amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES April 14, 2026 Mr. McCormick (for himself and Ms. DeLauro) introduced the following bill; which was referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned _______________________________________________________________________ A BILL To amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Consumer Labeling for Enhanced API R…
Summarized by Claude AI · Non-partisan · For informational purposes only